Recombinant human VASH1   

Vasohibin; KIAA1036; VASH; VASH; VASH1; VASH1_HUMAN; Vasohibin1; Vasohibin-1   

濃度：1mg/ ml

來源：Recombinant Human

純度：≥95% SDS-PAGE

表達系統：Wheat germ

標簽：GST tag N-Terminus

蛋白長度：Full length protein

內毒素水平：<1.000 Eu/µg

純化方法：HPLC

應用：SDS-PAGE，Western blot，ELISA

Biological activity,immunology research

保存：-20℃

保質期：1年

VASH1 is a angiogenesis inhibitor. It inhibits migration, proliferation and network formation by endothelial cells as well as angiogenesis. This inhibitory effect is selective to endothelial cells as it does not affect the migration of smooth muscle cells or fibroblasts. It does not affect the proliferation of cancer cells in vitro, but inhibits tumor growth and tumor angiogenesis and acts in an autocrine manner. VASH1 also inhibits artery neointimal formation and macrophage infiltration and exhibits heparin-binding activity. There are two named isoforms.

產品名稱：Rabbit Anti-VASH1  antibody

Rabbit Anti-VASH1  

別名：Vasohibin; KIAA1036; VASH; VASH; VASH1; VASH1_HUMAN; Vasohibin1; Vasohibin-1

來源：Rabbit

克隆類型：Polyclonal

濃度：1mg/ml

亞型：IgG

應用： WB=1:1000-1:2000,Elisa=1:1000-1:2000,IHC-P=1:100-500,IHC-F=1:100-500,ICC/IF=1:100-500,IF=1:100-500

反應：Human,Rat (predicted: Mouse,Rabbit,Pig,Cow,Dog,Horse)

理論分子量：41kDa

免疫原：KLH conjugated synthetic peptide derived from human VASH1

保存：-20℃
保質期：1年

單克隆抗體

產品名稱：Anti-VASH1 antibody

Mouse Anti-VASH1 

別名：Vasohibin; KIAA1036; VASH; VASH; VASH1; VASH1_HUMAN; Vasohibin1; Vasohibin-1

來源：Mouse

克隆類型：Monoclonal

濃度：1mg/ml

亞型：IgG

應用： WB=1:1000-1:2000,Elisa=1:1000-1:2000,IHC-P=1:100-500,IHC-F=1:100-500,ICC/IF=1:100-500,IF=1:100-500

反應: Human

理論分子量：41kDa

免疫原：KLH conjugated synthetic peptide derived from human VASH1

保存：-20℃
保質期：1年

VASH1 is a angiogenesis inhibitor. It inhibits migration, proliferation and network formation by endothelial cells as well as angiogenesis. This inhibitory effect is selective to endothelial cells as it does not affect the migration of smooth muscle cells or fibroblasts. It does not affect the proliferation of cancer cells in vitro, but inhibits tumor growth and tumor angiogenesis and acts in an autocrine manner. VASH1 also inhibits artery neointimal formation and macrophage infiltration and exhibits heparin-binding activity. There are two named isoforms.